ArticleJournal of medical signals and sensors2024
Joint Brain Tumor Segmentation from Multi-magnetic Resonance Sequences through a Deep Convolutional Neural Network.
Article in Journal of medical signals and sensors, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Brain tumor segmentation using deep learning: high performance with minimized MRI data.Frontiers in radiology · 2025Article
- Predicting the Response of Patients Treated withJournal of medical signals and sensors · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Brain tumor segmentation is highly contributive in diagnosing and treatment planning. Manual brain tumor delineation is a time-consuming and tedious task and varies depending on the radiologist's skill. Automated brain tumor segmentation is of high importance and does not depend on either inter- or intra-observation. The objective of this study is to automate the delineation of brain tumors from the Fluid-attenuated inversion recovery (FLAIR), T1-weighted (T1W), T2-weighted (T2W), and T1W contrast-enhanced (T1ce) magnetic resonance (MR) sequences through a deep learning approach, with a focus on determining which MR sequence alone or which combination thereof would lead to the highest accuracy therein. Methods: The BraTS-2020 challenge dataset, containing 370 subjects with four MR sequences and manually delineated tumor masks, is applied to train a residual neural network. This network is trained and assessed separately for each one of the MR sequences (single-channel input) and any combination thereof (dual- or multi-channel input). Results: The quantitative assessment of the single-channel models reveals that the FLAIR sequence would yield higher segmentation accuracy compared to its counterparts with a 0.77 ± 0.10 Dice index. As to considering the dual-channel models, the model with FLAIR and T2W inputs yields a 0.80 ± 0.10 Dice index, exhibiting higher performance. The joint tumor segmentation on the entire four MR sequences yields the highest overall segmentation accuracy with a 0.82 ± 0.09 Dice index. Conclusion: The FLAIR MR sequence is considered the best choice for tumor segmentation on a single MR sequence, while the joint segmentation on the entire four MR sequences would yield higher tumor delineation accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.